Skip to main content
Caplight Logo









Hangzhou Ruidi Biotechnology Ltd.

Hangzhou Ruidi Biotechnology Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://ruidibiotech.com/

Last Round

Series B

Extension

Feb 11, 2025

Total Funding Raised

$48.1M

Company Overview

Hangzhou Ruidi Biotechnology Ltd. is a medical device company that develops nanosecond pulsed electric field (nsPEF) ablation systems for the treatment of solid tumors and other medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

pulsed electric fieldPEFnanosecond pulsed electric fieldnsPEFpulsed field ablationPFAtumor ablationcardiac ablationminimally invasive surgeryinterventional cardiologyinterventional oncologymedical device manufacturerelectroporationatrial fibrillation treatmentnon-thermal ablation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Ruidi Biotechnology Ltd. Comparables

Compare Hangzhou Ruidi Biotechnology Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Ruidi Biotechnology Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulsecare Medical
85%
Remedicine Co., Ltd.
83%
Galvanize Therapeutics
78%

Hangzhou Ruidi Biotechnology Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 11, 2025
Series BOct 17, 2021
Series A ExtensionOct 28, 2020
Series AFeb 18, 2019

Hangzhou Ruidi Biotechnology Ltd. Investors

Notable investors and investment history

Hangzhou Ruidi Biotechnology Ltd. investors
InvestorRounds
Jifeng VenturesSeries B
Zhangjiang Shuifeng Innovation Equity Investment FundSeries B Extension
Proxima Ventures Ltd.Angel, Series A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2025

    $14M round with Zhangjiang Shuifeng Innovation and He Haichao.

  • Feb 18, 2019

    $3M round led by Proxima Ventures Ltd.

Hangzhou Ruidi Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hangzhou Ruidi Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hangzhou Ruidi Biotechnology Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2014
Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.